All News #Library
Sciences
BrainStorm Cell Therapeutics Announces Pricing of $4.0 M Direct Offering
27 Jun 2024 //
PR NEWSWIRE
BrainStorm Presents ALS Biomarker Data For Longer NurOwn Benefit
20 May 2024 //
PR NEWSWIRE
Following Biogen, BrainStorm analyzes ALS cell therapy biomarker
07 Jul 2023 //
FIERCE BIOTECH
BrainStorm Announces Positive Topline Data in Phase 2 Study Evaluating NurOwn®
24 Mar 2021 //
PRNEWSWIRE
BrainStorm climbs on stem cell data from small MS trial
24 Mar 2021 //
FIERCEBIOTECH
BrainStorm Announces Groundbreaking Pre-Clinical Study of NurOwn®
23 Jul 2020 //
GLOBENEWSWIRE

Market Place
Sourcing Support